These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9299969)
1. Interferences of o-raffinose cross-linked hemoglobin in three methods for serum creatinine. Ali AC; Mihas CC; Campbell JA Clin Chem; 1997 Sep; 43(9):1738-43. PubMed ID: 9299969 [TBL] [Abstract][Full Text] [Related]
2. Interference of o-raffinose cross-linked hemoglobin with routine Hitachi 717 assays. Ali AC; Campbell JA Clin Chem; 1997 Sep; 43(9):1794-6. PubMed ID: 9299984 [No Abstract] [Full Text] [Related]
3. Evaluation of HemogloBind for removal of o-raffinose cross-linked hemoglobin (Hemolink) from serum. Balion CM; Champagne PA; Ali AC Clin Chem; 1997 Sep; 43(9):1796-7. PubMed ID: 9299985 [No Abstract] [Full Text] [Related]
4. A phase I study of oxidized raffinose cross-linked human hemoglobin. Carmichael FJ; Ali AC; Campbell JA; Langlois SF; Biro GP; Willan AR; Pierce CH; Greenburg AG Crit Care Med; 2000 Jul; 28(7):2283-92. PubMed ID: 10921554 [TBL] [Abstract][Full Text] [Related]
5. The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs. Kingma JG; Sandhu R; Hamelin ND; Gendron D; Trudel Y; Bosa M; Stewart R; Fargey MB; Biro GP Artif Cells Blood Substit Immobil Biotechnol; 2002 Mar; 30(2):137-54. PubMed ID: 12027229 [TBL] [Abstract][Full Text] [Related]
6. Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer. Badiou S; Dupuy AM; Descomps B; Cristolead JP J Clin Lab Anal; 2003; 17(6):235-40. PubMed ID: 14614747 [TBL] [Abstract][Full Text] [Related]
7. Hemolink-induced effects on intestinal motor function and attenuation of these effects by selected agents. Wong LT; Er SS; Ning J; Christoff B; Carmichael FJ Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):529-48. PubMed ID: 9844719 [TBL] [Abstract][Full Text] [Related]
8. Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. Ma Z; Monk TG; Goodnough LT; McClellan A; Gawryl M; Clark T; Moreira P; Keipert PE; Scott MG Clin Chem; 1997 Sep; 43(9):1732-7. PubMed ID: 9299968 [TBL] [Abstract][Full Text] [Related]
9. Hemolink, an o-raffinose cross-linked haemoglobin-based oxygen carrier, does not affect activation and function of human platelets in whole blood in vitro. Leytin V; Mazer D; Mody M; Garvey B; Freedman J Br J Haematol; 2003 Feb; 120(3):535-41. PubMed ID: 12580976 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery. Cheng DC Can J Anaesth; 2001 Apr; 48(4 Suppl):S41-8. PubMed ID: 11336436 [TBL] [Abstract][Full Text] [Related]
11. The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogs. Wicks D; Wong LT; Sandhu R; Stewart RK; Biro GP Artif Cells Blood Substit Immobil Biotechnol; 2003 Feb; 31(1):1-17. PubMed ID: 12602813 [TBL] [Abstract][Full Text] [Related]
12. Exogenous interferences with Jaffe creatinine assays: addition of sodium dodecyl sulfate to reagent eliminates bilirubin and total protein interference with Jaffe methods. Srisawasdi P; Chaichanajarernkul U; Teerakanjana N; Vanavanan S; Kroll MH J Clin Lab Anal; 2010; 24(3):123-33. PubMed ID: 20486190 [TBL] [Abstract][Full Text] [Related]
13. Lactate measurement interference by hemoglobin-based oxygen carriers (Oxyglobin, Hemopure, and Hemolink). Jahr JS; Osgood S; Rothenberg SJ; Li QL; Butch AW; Gunther R; Cheung A; Driessen B Anesth Analg; 2005 Feb; 100(2):431-436. PubMed ID: 15673871 [TBL] [Abstract][Full Text] [Related]